33 results
8-K
EX-99.1
LGVN
Longeveron Inc - Ordinary Shares
10 May 24
Longeveron Announces Board of Directors Planned Transitions
4:30pm
for their leadership, service and countless contributions,” said Joshua Hare, M.D., Co-founder, Chief Science Officer and Chairman of the Board … leadership of biopharmaceutical licensing transactions will bring tremendous value to Longeveron as we continue to advance Lomecel-BTM, our
8-K
LGVN
Longeveron Inc - Ordinary Shares
20 Jul 23
Longeveron Appoints Lisa Locklear as Chief Financial Officer
8:30am
” or the “Company”) announced the appointment of Lisa Locklear to the Longeveron executive leadership team in the role of Executive Vice President and Chief
8-K
EX-99.1
LGVN
Longeveron Inc - Ordinary Shares
20 Jul 23
Longeveron Appoints Lisa Locklear as Chief Financial Officer
8:30am
as of July 31, 2023.
“Lisa brings to Longeveron keen strategic perspective and expansive industry knowledge, and her financial leadership ability … to welcome Lisa to our executive leadership team.”
“I am intrigued by the potential of Lomecel-B™ in therapeutic areas in critical need of innovation
8-K
srshwj
5 Jul 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
vbx1fp7
23 Jun 23
Regulation FD Disclosure
8:00am
DEF 14A
qfq6wo
13 May 22
Definitive proxy
4:10pm
8-K
EX-99.1
jx5 ejpo2
9 May 22
Longeveron Announces CEO Transition
4:26pm
8-K
7h6b3 uaiz66
5 Apr 22
Longeveron Expands Executive Leadership Team; Appoints
4:01pm
8-K
EX-99.1
nhxmwtak5znarptv 42
5 Apr 22
Longeveron Expands Executive Leadership Team; Appoints
4:01pm
8-K
EX-99.1
vsiot
17 Feb 22
Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of Directors
4:02pm
8-K
EX-99.1
dkxjiq
10 Jan 22
Regulation FD Disclosure
10:38am
424B3
4nihr8t5 ab
22 Dec 21
Prospectus supplement
5:07pm
8-K
EX-99.1
rl27ni
1 Oct 21
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
qpccutsbr1qiy6g wn
13 Aug 21
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2021 Financial Results
10:32am